The peer-authored management source for clinical lab professionals since 1969.
Continuing Education
Diagnostics
Disease
Management
Molecular
Sections
Continuing Education
Diagnostics
Disease
Management
Molecular
Information Technology
Online Exclusives
Special
Magazine
Newsletter
Webinars
White Papers
eBooks
Clinical Laboratory Reference
Videos
Contact
About Us
Magazine Subscription
Newsletter Subscription
Advertise
Contact Us
Affiliated Brands
HEALTHCARE PURCHASING NEWS
HEALTHCARE INNOVATION
Follow us on
https://www.facebook.com/MLOMedicalLaboratoryObserver
https://www.linkedin.com/company/medical-laboratory-observer
https://twitter.com/MedicalLabMLO
MDX
ID 10474132 © Alexander Raths | Dreamstime.com
MDX
QuidelOrtho announces strategy to accelerate growth in molecular diagnostics
QuidelOrtho Corporation announced a refocusing of its molecular diagnostics strategy. This strategy includes the intent to acquire full ownership of LEX Diagnostics after...
June 5, 2025
ID 361325299 © Yuri Arcurs | Dreamstime.com
MDX
Syndromic tests expand the medical laboratory’s growing stewardship role
March 21, 2025
ID 215927108 © Hulko Svitlana | Dreamstime.com
MDX
Blood test could improve lung cancer outcomes, Yale finds
March 17, 2025
ID 211428312 © Andrei Ivanov | Dreamstime.com
MDX
Fluxergy announces NIAID collaboration
Nov. 21, 2024
MDX
Q&A with Nathan Patton, vice president of marketing for Near Patient Care at Roche Diagnostics
Oct. 30, 2024
MDX
Q&A with Jackie Weiss, PhD, scientific affairs liaison at EUROIMMUN US (part of Revvity)
Oct. 29, 2024
ID 88421052 © Mkarco | Dreamstime.com
MDX
MLO releases findings of 2024 SOI survey on MDx
Oct. 28, 2024
urfinguss/iStock/Getty Images Plus/Getty Images
MDX
Navigating the landscape of hepatitis B: Symptoms, causes, and testing
June 24, 2024
Photo 55304069 © Pleprakaymas | Dreamstime.com
MDX
Diasorin receives FDA 510(K) Clearance for the LIAISON PLEX Blood Culture Yeast Assay on the new multiplexing LIAISON PLEX
June 6, 2024
Looking for Something?
Load More Content
Back To Top